MedTrace Logo

Study of Branched-chain Amino Acids in Cancer Cachexia

NCT03253029 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-08-24

No results posted yet for this study

Summary

Investigate whether supplementation with branched-chain amino acids (BCAAs) has a positive effect on cancer cachexia, as measured by the maintenance or increase in weight and lean body mass (LBM) based on body weight in kilograms (kg) and bioelectrical impedance assessment (BIA).

Conditions

  • Cancer Cachexia

Interventions

DIETARY_SUPPLEMENT

Pure Encapsulations Branched Chain Amino Acid powder

DIETARY_SUPPLEMENT

control group (no BCAAs provided)

Sponsors & Collaborators

  • Western Regional Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-04-30
Completion
2016-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03253029 on ClinicalTrials.gov